Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin.

Pharmacogenetics and genomics - 1 Jun 2007

Deakin Sara, Guernier Sophie, James Richard W

Abstract excerpt

OBJECTIVE: The aims of this study were to compare the impact of transcription factors, together with statin, on the paraoxonase promoter alleles defined by the C(-107T) polymorphism and to more clearly define regions of the paraoxonase promoter implicated in the actions of transcription factors. METHODS: Expression studies of promoter alleles were performed with reporter gene cassettes transfected into HepG2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryldialkylphosphatase
Share to Genes, Reporter
Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Recombinant Proteins

Share to Simvastatin

Share to Sp1 Transcription Factor

Share to Sterol Regulatory Element Binding Protein 2

Source

Identifiers

PMID: 17502837
DOI: 10.1097/FPC.0b013e3280925716

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin.PMID 17502837Read ↗

Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients.Semantic proximity Read ↗

The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults.Semantic proximity Read ↗

Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease.Semantic proximity Read ↗

Mutation -59c-->t in repeat 2 of the LDL receptor promoter: reduction in transcriptional activity and possible allelic interaction in a South African family with familial hypercholesterolaemia.Semantic proximity Read ↗

Polymorphisms in the human paraoxonase (PON1) promoterSemantic proximity Read ↗

Cholesteryl ester transfer protein promoter single-nucleotide polymorphisms in Sp1-binding sites affect transcription and are associated with high-density lipoprotein cholesterol.Semantic proximity Read ↗

The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.Semantic proximity Read ↗

Functional promoter polymorphism in SREBP cleavage-activating protein (SCAP).Semantic proximity Read ↗

Identification of a gene variant in the master regulator of lipid metabolism SREBP-1 in a family with a novel form of severe combined hypolipidemia.Semantic proximity Read ↗

Promoter variant -204A > C of the cholesterol 7α-hydroxylase gene: association with response to plant sterols in humans and increased transcriptional activity in transfected HepG2 cells.Semantic proximity Read ↗

Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene.Semantic proximity Read ↗

Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.